SOL Capital Management CO continued to hold its stake in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,586 shares of the medical research company’s stock at the end of the second quarter. SOL Capital Management CO’s holdings in Agilent Technologies were worth $331,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of A. Garde Capital Inc. increased its stake in Agilent Technologies by 4.2% in the fourth quarter. Garde Capital Inc. now owns 13,341 shares of the medical research company’s stock valued at $608,000 after buying an additional 539 shares in the last quarter. Kentucky Retirement Systems bought a new stake in Agilent Technologies during the fourth quarter valued at about $1,072,000. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Agilent Technologies during the fourth quarter valued at about $478,000. Chevy Chase Trust Holdings Inc. increased its stake in Agilent Technologies by 2.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 280,055 shares of the medical research company’s stock valued at $14,807,000 after buying an additional 6,577 shares in the last quarter. Finally, CENTRAL TRUST Co increased its stake in Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares in the last quarter.
Shares of Agilent Technologies, Inc. (A) opened at 59.33 on Friday. The stock has a market capitalization of $19.06 billion, a price-to-earnings ratio of 33.35 and a beta of 1.30. The firm’s 50-day moving average is $60.10 and its 200 day moving average is $55.69. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $61.84.
Agilent Technologies (NYSE:A) last posted its earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The firm had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the firm posted $0.44 EPS. The business’s quarterly revenue was up 8.1% on a year-over-year basis. Equities analysts expect that Agilent Technologies, Inc. will post $2.23 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd were issued a $0.132 dividend. The ex-dividend date of this dividend was Thursday, June 29th. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.89%. Agilent Technologies’s dividend payout ratio (DPR) is presently 29.78%.
COPYRIGHT VIOLATION NOTICE: “Agilent Technologies, Inc. (A) Position Held by SOL Capital Management CO” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.com-unik.info/2017/08/12/agilent-technologies-inc-a-stake-maintained-by-sol-capital-management-co-updated-updated.html.
Several research firms have recently weighed in on A. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price target on the stock in a report on Tuesday, May 16th. Deutsche Bank AG upped their price target on shares of Agilent Technologies from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Monday, May 22nd. Cowen and Company upped their price target on shares of Agilent Technologies from $53.00 to $62.00 and gave the stock a “market perform” rating in a report on Tuesday, May 23rd. Jefferies Group LLC upped their price target on shares of Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a report on Tuesday, May 23rd. Finally, Robert W. Baird upped their price target on shares of Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a report on Wednesday, May 24th. Two analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $60.12.
In related news, CEO Michael R. Mcmullen sold 50,000 shares of the company’s stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $59.86, for a total transaction of $2,993,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction dated Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the transaction, the insider now owns 45,138 shares in the company, valued at $2,765,153.88. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 112,608 shares of company stock worth $6,737,509.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
What are top analysts saying about Agilent Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies Inc. and related companies.